| In-silico screening of inhibitor on protein epidermal growth factor receptor (EGFR) J Ongko, JV Setiawan, AG Feronytha, A Juliana, A Effraim, M Wahjudi, ... IOP conference series: earth and environmental science 1041 (1), 012075, 2022 | 14 | 2022 |
| Molecular docking of active compounds from traditional medicinal plants as ACE-2 protein (1R4L) inhibitor in searching for COVID-19 drug E Tungary, J Ongko, J Sukweenadhi, Y Antonius Research Journal of Pharmacy and Technology 15 (9), 4235-4240, 2022 | 12 | 2022 |
| Identification of potential activity of volatile compounds derived from pogostemon Cablin benth as antiviral of SARS-CoV-2 Y Antonius, J Ongko, PH Hardjo International Journal of Applied Pharmaceutics (Int J App Pharm) 15 (1), 93-97, 2023 | 9 | 2023 |
| Identification of potential Ebola virus nucleoprotein (EBOV NP) inhibitor derivate from various traditional medicinal plants in Indonesia: in silico study Y Antonius, J Ongko, J Sukweenadhi, SED Putra Media Pharmaceutica Indonesiana 3 (4), 217-226, 2021 | 2 | 2021 |
| Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs P Silvia, J Ongko, Y Antonius Journal of Pharmacy & Pharmacognosy Research 12 (5), 881-891, 2024 | | 2024 |
| Epidermal growth factor receptor mutant inhibitors as NSCLC drugs P Silvia, J Ongko, Y Antonius | | |
Yulanda AntoniusUniversity of SurabayaEmail yang diverifikasi di staff.ubaya.ac.id
